News analysis

China’s decision not to import mRNA vaccines leaves it in a bind

As China shifts away from its zero-Covid approach, experts say it is probably too late to import mRNA vaccines. PHOTO: AFP
Gift this subscriber-only story to your friends and family

BEIJING - Early on in the pandemic, mRNA Covid-19 vaccines produced by Pfizer-BioNTech and Moderna were widely shown to be more effective than Chinese-made shots, but Beijing made the decision not to import these foreign vaccines.

China instead bet that local vaccine makers would be able to catch up and develop more effective shots, a decision that experts say was motivated by vaccine nationalism and national security concerns.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.